<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02182843</url>
  </required_header>
  <id_info>
    <org_study_id>CS-092</org_study_id>
    <nct_id>NCT02182843</nct_id>
  </id_info>
  <brief_title>Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)</brief_title>
  <acronym>VCBM/ACDF</acronym>
  <official_title>Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the clinical and radiographic outcomes in patients who
      undergo ACDF procedures using Cellentra Viable Cell Bone Matrix (VCBM), cortical allograft
      spacers, and the MaxAn® Anterior Cervical Plate System. Cellentra VCBM will be compared to
      published data for autograft in NDI (Neck Disability Index) improvement and radiographic
      success of fusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective single-arm multi-center study of Cellentra Viable Cell Bone Matrix
      (VCBM) and the MaxAn® Anterior Cervical Plate System when used in anterior cervical
      discectomy and fusion procedures. This study will enroll up to eighty (80) subjects across up
      to eight (8) clinical sites. Subjects will be recruited from a pool of patients presenting to
      investigators for an anterior cervical discectomy and fusion procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Reported Outcomes</measure>
    <time_frame>24 Months</time_frame>
    <description>The primary measure of effectiveness will be assessed by the improvement in the Neck Disability Index (NDI) score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic Fusion</measure>
    <time_frame>24 Months</time_frame>
    <description>The secondary measure of effectiveness will be determined by fusion rates.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Cervical Disc Degenerative Disorder</condition>
  <arm_group>
    <arm_group_label>Cellentra VCBM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cellentra™ VCBM is an allogenic bone graft containing naturally occurring viable donor cells intended for homologous use in the repair, replacement, reconstruction or supplementation of the recipient's tissue in musculoskeletal defects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cellentra VCBM</intervention_name>
    <description>Cellentra™ VCBM is an allogenic bone graft containing naturally occurring viable donor cells intended for homologous use in the repair, replacement, reconstruction or supplementation of the recipient's tissue in musculoskeletal defects.</description>
    <arm_group_label>Cellentra VCBM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is scheduled to undergo a two or three level primary spinal fusion surgery
             between the levels of C2-T1 (Cervical 2 to Thoracic 1) using Cellentra™ VCBM,
             allograft spacers, and the MaxAn® Anterior Cervical Plate System.

          -  The subject is 18 years of age or older.

          -  The subject was unresponsive to conservative treatment for at least 6 weeks unless
             clinically indicated sooner.

          -  The subject has persistent neck, shoulder, or arm pain consistent with cervical
             degenerative disc disease confirmed by patient history and radiographic studies.

          -  The subject must in the investigator's opinion, be psychosocially, mentally, and
             physically able to fully comply with this protocol including the required follow-up
             visits, the filling out of required forms, and have the ability to understand and give
             written informed consent.

        Exclusion Criteria:

          1. Subject has an active local or systemic infection.

          2. Subject is morbidly obese, defined as a BMI greater than 40.

          3. Subject has a history (present or past) of substance abuse (recreational drugs,
             prescription drugs or alcohol) that in the investigator's opinion may interfere with
             protocol assessments and/or with the subject's ability to complete the protocol
             required follow-up.

          4. Subject has inadequate tissue coverage over the operative site.

          5. Subject has an open wound local to the operative area, or rapid joint disease, bone
             absorption, osteopenia, osteomalacia and/or osteoporosis.

          6. Any previous cervical spinal surgery.

          7. Subject has a condition requiring medications that may interfere with bone or soft
             tissue healing (i.e., oral or parenteral glucocorticoids, immunosuppressives,
             methotrexate, etc.) or immunocompromised.

          8. Subject has any medical condition or extenuating circumstance that, in the opinion of
             the investigator, would preclude participation in the study.

          9. Subject who does not meet the specific indications for use of the Cellentra™ VCBM or
             MaxAn® Anterior Cervical Plate System.

         10. Subject is pregnant, lactating or interested in becoming pregnant during the duration
             of the study.

         11. Subject is currently involved in another investigational drug or device study that
             could confound study data.

         12. Subject is a prisoner.

         13. Subject has a metal sensitivity/foreign body sensitivity.

         14. Subject is involved in or planning to engage in litigation or receiving Worker's
             Compensation related to neck or back pain.

         15. Subject has sensitivity or allergies to any of the processing agents. (See package
             insert for Cellentra™ VCBM).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Batts</last_name>
    <role>Study Director</role>
    <affiliation>Biomet Spine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barrow Neurological Associates</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Wayne Ortho</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Institute of Western KY</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <zip>42001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Team Texas</name>
      <address>
        <city>Southlake</city>
        <state>Texas</state>
        <zip>75032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gore DR, Sepic SB. Anterior cervical fusion for degenerated or protruded discs. A review of one hundred forty-six patients. Spine (Phila Pa 1976). 1984 Oct;9(7):667-71.</citation>
    <PMID>6505833</PMID>
  </reference>
  <reference>
    <citation>Palit M, Schofferman J, Goldthwaite N, Reynolds J, Kerner M, Keaney D, Lawrence-Miyasaki L. Anterior discectomy and fusion for the management of neck pain. Spine (Phila Pa 1976). 1999 Nov 1;24(21):2224-8.</citation>
    <PMID>10562988</PMID>
  </reference>
  <reference>
    <citation>McConnell JR, Freeman BJ, Debnath UK, Grevitt MP, Prince HG, Webb JK. A prospective randomized comparison of coralline hydroxyapatite with autograft in cervical interbody fusion. Spine (Phila Pa 1976). 2003 Feb 15;28(4):317-23.</citation>
    <PMID>12590203</PMID>
  </reference>
  <reference>
    <citation>Samartzis D, Shen FH, Goldberg EJ, An HS. Is autograft the gold standard in achieving radiographic fusion in one-level anterior cervical discectomy and fusion with rigid anterior plate fixation? Spine (Phila Pa 1976). 2005 Aug 1;30(15):1756-61.</citation>
    <PMID>16094278</PMID>
  </reference>
  <reference>
    <citation>Bridwell KH, Lenke LG, McEnery KW, Baldus C, Blanke K. Anterior fresh frozen structural allografts in the thoracic and lumbar spine. Do they work if combined with posterior fusion and instrumentation in adult patients with kyphosis or anterior column defects? Spine (Phila Pa 1976). 1995 Jun 15;20(12):1410-8.</citation>
    <PMID>7676341</PMID>
  </reference>
  <reference>
    <citation>Söderlund CH, Pointillart V, Pedram M, Andrault G, Vital JM. Radiolucent cage for cervical vertebral reconstruction: a prospective study of 17 cases with 2-year minimum follow-up. Eur Spine J. 2004 Dec;13(8):685-90. Epub 2004 Jun 26.</citation>
    <PMID>15662542</PMID>
  </reference>
  <reference>
    <citation>Fountas KN, Kapsalaki EZ, Nikolakakos LG, Smisson HF, Johnston KW, Grigorian AA, Lee GP, Robinson JS Jr. Anterior cervical discectomy and fusion associated complications. Spine (Phila Pa 1976). 2007 Oct 1;32(21):2310-7. Review.</citation>
    <PMID>17906571</PMID>
  </reference>
  <reference>
    <citation>Carreon LY, Glassman SD, Campbell MJ, Anderson PA. Neck Disability Index, short form-36 physical component summary, and pain scales for neck and arm pain: the minimum clinically important difference and substantial clinical benefit after cervical spine fusion. Spine J. 2010 Jun;10(6):469-74. doi: 10.1016/j.spinee.2010.02.007. Epub 2010 Apr 1.</citation>
    <PMID>20359958</PMID>
  </reference>
  <reference>
    <citation>Young BA, Walker MJ, Strunce JB, Boyles RE, Whitman JM, Childs JD. Responsiveness of the Neck Disability Index in patients with mechanical neck disorders. Spine J. 2009 Oct;9(10):802-8. doi: 10.1016/j.spinee.2009.06.002. Epub 2009 Jul 25.</citation>
    <PMID>19632904</PMID>
  </reference>
  <reference>
    <citation>Coric D, Nunley PD, Guyer RD, Musante D, Carmody CN, Gordon CR, Lauryssen C, Ohnmeiss DD, Boltes MO. Prospective, randomized, multicenter study of cervical arthroplasty: 269 patients from the Kineflex|C artificial disc investigational device exemption study with a minimum 2-year follow-up: clinical article. J Neurosurg Spine. 2011 Oct;15(4):348-58. doi: 10.3171/2011.5.SPINE10769. Epub 2011 Jun 24. Erratum in: J Neurosurg Spine. 2012 Mar;16(3):322.</citation>
    <PMID>21699471</PMID>
  </reference>
  <reference>
    <citation>Davis RJ, Kim KD, Hisey MS, Hoffman GA, Bae HW, Gaede SE, Rashbaum RF, Nunley PD, Peterson DL, Stokes JK. Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article. J Neurosurg Spine. 2013 Nov;19(5):532-45. doi: 10.3171/2013.6.SPINE12527. Epub 2013 Sep 6.</citation>
    <PMID>24010901</PMID>
  </reference>
  <reference>
    <citation>Löfgren H, Engquist M, Hoffmann P, Sigstedt B, Vavruch L. Clinical and radiological evaluation of Trabecular Metal and the Smith-Robinson technique in anterior cervical fusion for degenerative disease: a prospective, randomized, controlled study with 2-year follow-up. Eur Spine J. 2010 Mar;19(3):464-73. doi: 10.1007/s00586-009-1161-z. Epub 2009 Sep 18.</citation>
    <PMID>19763634</PMID>
  </reference>
  <reference>
    <citation>Miller LE, Block JE. Safety and effectiveness of bone allografts in anterior cervical discectomy and fusion surgery. Spine (Phila Pa 1976). 2011 Nov 15;36(24):2045-50. doi: 10.1097/BRS.0b013e3181ff37eb. Review.</citation>
    <PMID>21304437</PMID>
  </reference>
  <reference>
    <citation>Mummaneni PV, Burkus JK, Haid RW, Traynelis VC, Zdeblick TA. Clinical and radiographic analysis of cervical disc arthroplasty compared with allograft fusion: a randomized controlled clinical trial. J Neurosurg Spine. 2007 Mar;6(3):198-209.</citation>
    <PMID>17355018</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2014</study_first_submitted>
  <study_first_submitted_qc>July 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2014</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cellentra ACDF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

